Compile Data Set for Download or QSAR
maximum 50k data
Found 97 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 11822
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650996((5aSa,17aRa)-20-chloro-2- [(2S,5R)-2,5-dimethyl-4-...)
Affinity DataIC50:  0.510nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572114(CHEMBL4852458 | US20240043448, Example 74)
Affinity DataIC50:  0.510nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651033(US20240043448, Example 97)
Affinity DataIC50:  0.560nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651028(2'-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazi...)
Affinity DataIC50:  0.710nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650997(2-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazin...)
Affinity DataIC50:  0.740nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572113(CHEMBL4879271 | US20240043448, Example 59)
Affinity DataIC50:  0.910nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650991(US20240043448, Example 51-1)
Affinity DataIC50:  1nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650995((5aRa,18aRa)-2-[(2S,5R)-2,5- dimethyl-4-(prop-2- e...)
Affinity DataIC50:  1.10nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651024(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  1.10nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650990(US20240043448, Example 50)
Affinity DataIC50:  1.10nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572117(CHEMBL4863593 | US20240043448, Example 91)
Affinity DataIC50:  1.40nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650999(2'-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazi...)
Affinity DataIC50:  1.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572115(CHEMBL4864188 | US20240043448, Example 75)
Affinity DataIC50:  1.70nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650992(US20240043448, Example 52)
Affinity DataIC50:  1.80nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651008(US20240043448, Example 70)
Affinity DataIC50:  1.80nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572116(CHEMBL4855378 | US20240043448, Example 76)
Affinity DataIC50:  2.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651000(2'-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazi...)
Affinity DataIC50:  2.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651045(US20240043448, Example 109)
Affinity DataIC50:  2.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651014(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  2.40nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572108(CHEMBL4869082 | US20240043448, Example 4a)
Affinity DataIC50:  2.40nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651013(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  2.40nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650993(US20240043448, Example 54)
Affinity DataIC50:  2.40nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651031(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  2.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572119(CHEMBL4876119 | US20240043448, Example 119)
Affinity DataIC50:  2.60nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651016(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  2.60nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651015(15,18,21-trifluoro-2-[(2S)-2-methyl-4-(prop-2- eno...)
Affinity DataIC50:  2.60nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651004(12,12,17,18,21-pentafluoro-6- (propan-2-yl)-2-[4-(...)
Affinity DataIC50:  2.60nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650994((5aRa,18aRa)-2-[(2S,5R)-2,5- dimethyl-4-(prop-2- e...)
Affinity DataIC50:  2.70nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651017(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  2.90nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651030(US20240043448, Example 94)
Affinity DataIC50:  3.40nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651001(2'-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazi...)
Affinity DataIC50:  3.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572109(CHEMBL4870399 | US20240043448, Example 8)
Affinity DataIC50:  3.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651002(20-chloro-2-[(2S,5R)-2,5- dimethyl-4-(prop-2- enoy...)
Affinity DataIC50:  3.60nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651032(2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl)piperazin...)
Affinity DataIC50:  3.80nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650976(17,20-difluoro-2-[(2S)-2- methyl-4-(prop-2- enoyl)...)
Affinity DataIC50:  3.90nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50572110(CHEMBL4866126 | US20240043448, Example 10b)
Affinity DataIC50:  4.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651057(US20240043448, Example 120)
Affinity DataIC50:  4.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651007(2-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazin...)
Affinity DataIC50:  4.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651046(US20240043448, Example 110)
Affinity DataIC50:  4.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651005(12,12,17,18,21-pentafluoro-2- [(3R)-3-methyl-4-(pr...)
Affinity DataIC50:  5.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651003(2-[(2S,5R)-2,5-Dimethyl-4-(prop- 2-enoyl)piperazin...)
Affinity DataIC50:  5.70nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651018(20-chloro-2-[(2S,5R)-2,5-dimethyl-4-(prop-2- enoyl...)
Affinity DataIC50:  5.90nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651009(US20240043448, Example 73)
Affinity DataIC50:  6.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650980(2-[(2S,5R)-2,5-dimethyl-4- (prop-2-enoyl)piperazin...)
Affinity DataIC50:  6.5nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650986(US20240043448, Example 19a)
Affinity DataIC50:  6.80nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650970(US20240043448, Example 7)
Affinity DataIC50:  6.90nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650977(2-[(2S,5R)-2,5-dimethyl-4- (prop-2-enoyl)piperazin...)
Affinity DataIC50:  7.20nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650979(US20240043448, Example 14a | [(2S)-4-[17,20-difluo...)
Affinity DataIC50:  8.10nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650968(22-fluoro-2-[(2S)-2-methyl- 4-(prop-2-enoyl)pipera...)
Affinity DataIC50:  9.20nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650981(US20240043448, Example 16a)
Affinity DataIC50:  9.80nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 97 total ) | Next | Last >>
Jump to: